Effects of Active and PRT on Pain, Function and Temporospatial Gait Parameters in Runners With Plantar Fascitis
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Nov 9, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two different treatment techniques on pain and walking ability in male runners who have plantar fasciitis, a common foot condition that causes heel pain. Participants will be divided into two groups: one group will receive ultrasound therapy followed by a method called Active Release Technique, while the other group will receive ultrasound therapy followed by Positional Release Technique. Both treatments will take place over 12 sessions, three times a week for four weeks.
To be eligible for the study, participants must be male runners aged between 18 and 30 years who have been running for at least six months and have a positive windlass test, which indicates plantar fasciitis. However, individuals with recent foot or ankle injuries, certain medical conditions, or previous surgeries in the lower body may not qualify. If you decide to participate, you'll need to give your consent, and you can expect to attend the treatment sessions on alternate days for the duration of the trial. This study aims to understand how these treatments can improve pain and walking function for those affected by this condition.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male runners age between 18-30 years
- • Duration of running at least 6 months
- • Positive windlass test
- • Patients with unilateral or bilateral plantar fasciitis
- Exclusion Criteria:
- • Recent accidental foot or ankle injury
- • Previous lower-body surgical intervention within 6 months
- • Recent fractures in the lower limb (femur, tibia, fibula or foot bones) within 6 months
- • Diagnosed musculoskeletal disorders (rheumatoid arthritis, calcaneal spurs)
- • Diagnosed neuropathy, local and systemic neurologic disorders (including sciatica, tarsal tunnel syndrome, nerve entrapment of abductor digiti minimi and posterior tibial
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Faisalābad, Punjab, Pakistan
Patients applied
Trial Officials
Athar Azeem, Dpt
Principal Investigator
Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported